Sahajanand Medical Technologies has announced its initial public offering (IPO) with a price band set between ₹327 and ₹344 per share. This IPO is an offer for sale (OFS) of 1.38 crore shares by existing promoters and investors, with no fresh shares being issued by the company. The public subscription for the IPO will open on October 15, 2026, and close on October 19, 2026.
- The IPO is exclusively an offer for sale of 1.38 crore shares by promoters and existing investors.
- The price band is fixed between ₹327 and ₹344 per share.
- The subscription period is from October 15 to October 19, 2026.
- Investors can apply for a minimum of 43 shares and in multiples thereafter.
- Allocation of shares: 50% to qualified institutional buyers, 35% to retail investors, and 15% to non-institutional investors.
- No fresh issue component; proceeds go to selling shareholders.
What is the structure of Sahajanand Medical Technologies' IPO?
The IPO is structured as an offer for sale (OFS) where promoters and existing investors sell a total of 1.38 crore shares. Promoters such as Shree Hari Trust and investors including Dhirajkumar Savjibhai Vasoya, Samara Capital Markets Holding, Kotak Pre-IPO Opportunities, and NHPEA Sparkle Holding BV are selling their stakes. Since there is no fresh issue, the company will not receive any funds from this IPO. Instead, the money raised will go directly to the selling shareholders.
What products does Sahajanand Medical Technologies offer?
Sahajanand Medical Technologies is a medical devices company specializing in Class III and Class C/D devices. Their portfolio includes advanced medical devices used in vascular and structural heart interventions. The product categories include:
- VI products: Coronary intervention devices such as coronary balloons and coronary stents.
- SH products: Devices like transcatheter aortic valve implantation (TAVI) and occluders.
- Others: Peripheral drug-coated balloons (DCBs), renal stents, and various trading products.
How can investors participate in the IPO?
Investors interested in Sahajanand Medical Technologies' IPO can apply for a minimum of 43 shares, with additional shares in multiples of 43. The IPO allotment is divided as follows:
- 50% of shares reserved for qualified institutional buyers (QIBs).
- 35% reserved for retail individual investors.
- 15% reserved for non-institutional investors.
The company expects that listing on the stock exchange will increase its visibility and brand recognition. It will also provide liquidity to existing shareholders and create a public market for its equity shares in India.
Frequently Asked Questions
Q: Is Sahajanand Medical Technologies issuing new shares in this IPO?
A: No, this IPO is only an offer for sale by existing shareholders. There is no fresh issue of shares.
Q: When does the IPO subscription start and end?
A: The IPO subscription opens on October 15, 2026, and closes on October 19, 2026.
Q: What is the minimum number of shares one can apply for?
A: Investors can apply for a minimum of 43 shares and in multiples of 43 thereafter.
